GENSCRIPT BIO (01548) appointed John Anthony Quelch as an independent non-executive director.

15/11/2024

GMT Eight

GENSCRIPT BIO (01548) announced that Dr. John Anthony Quelch has been appointed as an independent non-executive director and member of the strategic committee of GENSCRIPT BIO Limited, effective from November 14, 2024.

Xiaoma Zhixing's IPO is priced at $11 to $13 per share, raising approximately $378 million, with Beijing Auto and Guangzhou Auto participating in the subscription.

Guotai Junan: Residents increase their allocation of equity products, improving market liquidity and benefiting brokerage sectors.

Contact: contact@gmteight.com

GENSCRIPT BIO (01548) appointed John Anthony Quelch as an independent non-executive director.

RECOMMEND

CHINAHONGQIAO (01378) Dragon Soars and Snake Dances: Strongly Positive Performance in the second half of the year, Can Next Year be Expected as well?

CMB International: Maintains a "buy" rating for FIT Hon Teng (06088) with a target price of HK$4.38.

HK Stock Market Move | HYGEIA HEALTH(06078) rises more than 5%, the company is expected to benefit from prepaid health insurance, cash flow and bad debt conditions may improve.